4.2 Article

Adverse Events and Immunogenicity of mRNA-Based COVID-19 Vaccine among Healthcare Workers: A Single-Centre Experience

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose

Oktavija Dakovic Rode et al.

Summary: Research on post-vaccination antibody dynamics is crucial in estimating COVID-19 vaccine efficacy. This study found that antibody levels significantly increased one month after vaccination and exponentially decreased three and six months after complete vaccination. Participants with a prior history of COVID-19 had higher antibody levels, particularly after the first dose. Six months after vaccination, antibody levels were comparable to those seen in COVID-19-naive participants after the first vaccine dose.

VACCINES (2022)

Editorial Material Public, Environmental & Occupational Health

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine

Saad Shakir et al.

DRUG SAFETY (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Review Immunology

SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines

Yuichiro J. Suzuki et al.

Summary: This article highlights the potential impact of the spike protein from COVID-19 vaccines on human host cells and emphasizes the need for careful monitoring of the long-term consequences. Further research on the effects of the SARS-CoV-2 spike protein on human cells and appropriate animal models is recommended.

VACCINES (2021)

Editorial Material Immunology

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines

John M. Kelso

VACCINE (2021)

Article Environmental Sciences

Effects of Natural Ventilation and Saliva Standard Ejectors during the COVID-19 Pandemic: A Quantitative Analysis of Aerosol Produced during Dental Procedures

Imena Rexhepi et al.

Summary: In dental procedures, using standard saliva ejectors can reduce the total amount of released PM10, thus decreasing the risk of exposure to SARS-CoV-2 in high-risk environments. On the other hand, natural ventilation may lead to increased particulate matter release, especially during scaling procedures.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)